Volume 3, Issue 2 (Fall & Winter 2019)                   J Res Urol 2019, 3(2): 41-48 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farhadi A, Behzad Behbahani A, Yaghobi R, Salehipour M. Prevalence of herpes simplex virus type 1 and 2 infections in renal transplant recipients and their renal function. J Res Urol 2019; 3 (2) :41-48
URL: http://urology.umsha.ac.ir/article-1-67-en.html
1- Assistant professor of Medical Virology, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran., Assistant professor of Medical Virology, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran , farhadi_a@sums.ac.ir
2- Professor of Medical Virology, Diagnosis Laboratory Sciences and Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Professor of Medical Virology, Diagnosis Laboratory Sciences and Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
3- Associate professor of Medical Virology, Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Associate professor of Medical Virology, Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
4- Associate professor of Urology, Department of urology, Shiraz University Medical Sciences, Shiraz, Iran, Associate professor of Urology, Department of urology, Shiraz University Medical Sciences, Shiraz, Iran
Abstract:   (4536 Views)
Background and Objectives: Viral infections are a major problem for transplant recipients. Reactivation of viruses is associated with the use of strong immunosuppressive drugs. Herpes simplex virus infections in renal transplant patients may become severe without treatment. Although the prevalence and role of herpes simplex viruses 1 and 2 in bone marrow and lung recipients are well known; however, the prevalence of the virus from the time of transplantation to the one-year period after transplantation is vague. The aim of this study was to investigate the prevalence of herpes simplex virus infections and renal function after transplantation.
Materials and Methods: In a prospective single-center study we followed 58 renal transplant recipients who received a living or cadaveric kidney transplant at Namazi hospital. Samples were taken from each individual 1 week before transplantation and 2 weeks post-transplantation. The patients were then sampled every 4 weeks up to 52 weeks after transplantation. Urine and blood samples were also collected from 37 organ donors. We investigated the presence of HSV-DNA in the urine and peripheral blood samples of renal transplant recipients using PCR-RFLP. The presence of viral DNA in the urine and peripheral blood samples of living donors were investigated as well. The patients were also examined for any signs or symptoms of renal dysfunction.
Results: HSV-1 DNA was detected in urine samples of only 19% of transplant patients. HSV-2 DNA, however, was not detected in any group of subjects including renal transplant recipients. A significant association was observed between HSV-1 infection among kidney recipients and donors (P=0.002).
Conclusion: Although there was no significant association between HSV-1 infection and renal dysfunction in renal transplant recipients, however, due to life-threatening infections caused by this virus, periodic testing for the presence of HSV-1 is recommended.
Full-Text [PDF 436 kb]   (2019 Downloads)    
Type of Study: Research | Subject: Endourology
Received: 2019/11/25 | Accepted: 2020/05/7 | Published: 2020/06/26

References
1. Akhtar J, Shukla D. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. The FEBS Journal. 2009; 276(24):7228-36. [DOI:10.1111/j.1742-4658.2009.07402.x] [PMID] [PMCID]
2. Shukla D, Spear PG. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. Journal of Clinical Investigation. 2001; 108(4):503-10. [DOI:10.1172/JCI200113799] [PMID] [PMCID]
3. Whitley RJ, Roizman B. Herpes simplex virus infections. The lancet. 2001; 357(9267):1513-8. [DOI:10.1016/S0140-6736(00)04638-9]
4. Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PloS One. 2015; 10(10): e0140765. [DOI:10.1371/journal.pone.0140765] [PMID] [PMCID]
5. Arduino PG, Porter S. Oral and perioral herpes simplex virus type 1 (HSV‐1) infection: review of its management. Oral Diseases. 2006; 12(3):254-7 [DOI:10.1111/j.1601-0825.2006.01202.x] [PMID]
6. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. Journal of Infection. 2000; 181(4):1454-7. [DOI:10.1086/315395] [PMID]
7. Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PloS One. 2015; 10(1): e114989. [DOI:10.1371/journal.pone.0114989] [PMID] [PMCID]
8. Johnston C, Corey L. Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding. Clinical Microbiology Reviews. 2016; 29(1):149-61. [DOI:10.1128/CMR.00043-15] [PMID] [PMCID]
9. Wilck M, Zuckerman R, Practice AIDCo. Herpes simplex virus in solid organ transplantation. American Journal of Transplantation. 2013; 13(s4):121-7. [DOI:10.1111/ajt.12105] [PMID]
10. Bernabeu-Wittel M, Naranjo M, Cisneros J, Canas E, Gentil M, Algarra G, et al. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression. European Journal of Clinical Microbiology & Infectious Diseases. 2002; 21(3):173-80. [DOI:10.1007/s10096-001-0684-y] [PMID]
11. Kotton CN, Fishman JA. Viral infection in the renal transplant recipient. Clinical Journal of the American Society of Nephrology. 2005; 16(6):1758-74. [DOI:10.1681/ASN.2004121113] [PMID]
12. Sarikonda G, von Herrath MG. Immunosuppressive mechanisms during viral infectious diseases. Suppression and Regulation of Immune Responses: Springer; 2010. p. 431-47. [DOI:10.1007/978-1-60761-869-0_27] [PMID] [PMCID]
13. Ljungman P. β-Herpesvirus challenges in the transplant recipient. Journal of Infection. 2002; 186(Supplement-1): S99-S109. [DOI:10.1086/342962] [PMID]
14. Boeckh M, Nichols WG. Immunosuppressive effects of beta-herpesviruses. Herpes: The Journal of the IHMF. 2003; 10(1):12-6.
15. Babel N, Schwarzmann F, Prang N, Jaeger M, Wolf H, Kern F, et al. Association between epstein-barr virus infection and late acute transplant rejection in long-term transplant patients. Transplantation. 2001; 72(4):736-9. [DOI:10.1097/00007890-200108270-00031] [PMID]
16. Klapper PE, Cleator GM, Dennett C, Lewis AG. Diagnosis of herpes encephalitis via Southern blotting of cerebrospinal fluid DNA amplified by polymerase chain reaction. Journal of Medical Virology. 1990; 32(4):261-4. [DOI:10.1002/jmv.1890320413] [PMID]
17. Behzadbehbahani A, Klapper PE, Vallely PJ, Cleator GM. Detection of BK virus in urine by polymerase chain reaction: a comparison of DNA extraction methods. Journal of Virological Methods. 1997; 67(2):161-6. [DOI:10.1016/S0166-0934(97)00101-8]
18. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA. Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes. Nature. 1986; 324(6093):163. [DOI:10.1038/324163a0] [PMID]
19. Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2-United States, 1999-2010. Journal of Infection. 2013; 209(3):325-33. [DOI:10.1093/infdis/jit458] [PMID]
20. Gomez E, Melon S, De Ona M, Alvarez R, Laures A, Alvarez-Grande J. Disseminated herpes simplex virus infection in a renal transplant patient as possible cause of repeated urinary extravasations. Nephron. 1999; 82(1):59-64. [DOI:10.1159/000045368] [PMID]
21. Fillet AM. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients. Drugs & Aging. 2002; 19(5):343-54. [DOI:10.2165/00002512-200219050-00003] [PMID]
22. Kusne S, Schwartz M, Breinig MK, Dummer JS, Lee RE, Selby R, et al. Herpes simplex virus hepatitis after solid organ transplantation in adults. Journal of Infection. 1991; 163(5):1001-7. [DOI:10.1093/infdis/163.5.1001] [PMID] [PMCID]
23. Amenabar J, Duran M, Montejo M, Lampreabe I. Herpes simplex virus encephalitis in a renal transplant patient. Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia. 2006; 26(2):270-3.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Research in Urology

Designed & Developed by : Yektaweb